What are the most common side effects of OSELTAMIVIR PHOSPHATE?

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for OSELTAMIVIR PHOSPHATE. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Is OSELTAMIVIR PHOSPHATE the same as Oseltamivir Phosphate?

Oseltamivir Phosphate is a brand name for OSELTAMIVIR PHOSPHATE. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

OSELTAMIVIR PHOSPHATE

Q: What is OSELTAMIVIR PHOSPHATE used for?

OSELTAMIVIR PHOSPHATE (brand name Oseltamivir Phosphate) is a Antiviral (Influenza) indicated for 1 INDICATIONS AND USAGE Oseltamivir phosphate for oral suspension is an influenza neuraminidase inhibitor (NAI) indicated for: Treatment of acute.

Q: How does OSELTAMIVIR PHOSPHATE work?

OSELTAMIVIR PHOSPHATE works through the following mechanism: 12.1 Mechanism of Action Oseltamivir is an antiviral drug with activity against influenza virus [see Microbiology (12.4) ]..

Antiviral (Influenza)

Brand names: Oseltamivir Phosphate

Oral

Mechanism of Action

12.1 Mechanism of Action Oseltamivir is an antiviral drug with activity against influenza virus [see Microbiology (12.4) ].

Indications

1 INDICATIONS AND USAGE Oseltamivir phosphate for oral suspension is an influenza neuraminidase inhibitor (NAI) indicated for: Treatment of acute

Contraindications

• Stevens-Johnson Syndrome
• and erythema multiforme [see Warnings and Precautions (5.1) ] . Patients with known serious hypersensitivity to oseltamivir or any of the components of oseltamivir phosphate for oral suspension ( 4 )

FDA Warnings

5 WARNINGS AND PRECAUTIONS Serious skin/hypersensitivity reactions such as Stevens-Johnson Syndrome, toxic epidermal necrolysis and erythema multiforme: Discontinue oseltamivir phosphate for oral suspension and initiate appropriate treatment if allergic-like reactions occur or are suspected
1 ) Neuropsychiatric events: Patients with influenza, including those receiving oseltamivir phosphate for oral suspension, particularly pediatric patients, may be at an increased risk of confusion or abnormal behavior early in their illness
1 Serious Skin/Hypersensitivity Reactions Cases of anaphylaxis and serious skin reactions including toxic epidermal necrolysis, Stevens-Johnson Syndrome, and erythema multiforme have been reported in postmarketing experience with oseltamivir phosphate for oral suspension
The use of oseltamivir phosphate for oral suspension is contraindicated in patients with known serious hypersensitivity to oseltamivir phosphate for oral suspension [see Contraindications (4) and Adverse Reactions (6

Known Side Effects

8 documented side effects by frequency

Vomiting

>10%

Nausea

1-10%

Drug Not Working

1-10%

Diarrhea

1-10%

Shortness of Breath

1-10%

Headache

1-10%

Fever

1-10%

Rash

0.1-1%

Community Discussions

No community discussions found for OSELTAMIVIR PHOSPHATE yet.

Primary sources

Every figure on this page links back to its primary source. See data sources for full provenance.

DailyMed FDA label search → OSELTAMIVIR PHOSPHATE openFDA label JSON → OSELTAMIVIR PHOSPHATE FAERS adverse-event reports → OSELTAMIVIR PHOSPHATE ClinicalTrials.gov → completed Phase 2+ trials of OSELTAMIVIR PHOSPHATE

Compare With

1 available comparisons

vs OSELTAMIVIR

Formulations

Dosage Forms

Tablet

Route

Oral